Dr. Robert Jackson Sherertz, MD

Dr. Sherertz practices at Grand Strand Medical Center in Myrtle Beach, South Carolina, part of HCA Healthcare.

Dr. Sherertz's NPI, 1891770178, was assigned on December 9, 2005. Dr. Sherertz graduated from UVA School of Medicine in 1976. Dr. Sherertz's South Carolina license number on file is 34460.

Dr. Sherertz's primary practice is Grand Strand Medical Center, at 809 82nd Parkway, Myrtle Beach, SC 29572 in Horry County. The practice phone is (843) 692-1000.

Dr. Sherertz's primary practice is Grand Strand Medical Center in Myrtle Beach, South Carolina, part of HCA Healthcare. Dr. Sherertz is also affiliated with McLeod Health Loris. The medical group on file is Southeastern Hospitalist Services. Dmand AI also links Dr. Sherertz to 1 more hospital and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sherertz practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Sherertz's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Sherertz is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Sherertz's licenses on file in 3 states: South Carolina, North Carolina and Florida.

Dmand AI lists acute diabetes, acute respiratory failure, anemia, atherosclerosis, cardiac arrhythmia, chest pain, circulation problems and circulatory problems in extremities among the conditions Dr. Sherertz treats.

CMS data shows 1,107 Medicare services from Dr. Sherertz across 5 procedure codes in 2024, for 362 Medicare patients. Medicare paid $83,477 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 362 Medicare patients who saw Dr. Sherertz in 2024. The largest group is 75 to 84, with 154 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sherertz's median patient age at 71, with 47% women.

In 2024, Dr. Sherertz wrote 24 Medicare Part D claims. 100% of them were for generic drugs. They cover 2 drugs, with $370 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sherertz for performance year 2024, reported individually. Dr. Sherertz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 64 papers to Dr. Sherertz, published from 2007 to 2024. 2022 was the busiest year, with 2. The most frequent topics are Cross Infection, Catheterization, Central Venous and Catheters, Indwelling. Dr. Sherertz has published most often in Infect Control Hosp Epidemiol. Dr. Sherertz's most frequent co-authors are Kenneth H. Rand, MD, Philip M. Polgreen, MD and Jon Stuart Abramson, MD.

CMS Open Payments shows 37 general payments to Dr. Sherertz from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Inari Medical, Inc. paid the most, $196.

Dr. Sherertz graduated from UVA School of Medicine in 1976.

Dr. Sherertz is in network with 10 carriers, including Alliant Health Plans, Blue Cross Blue Shield of Massachusetts and HCSC. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.